British Society for Immunology. Allergy briefing. Retrieved 18 December 2023
https://www.immunology.org/policy-and-public-affairs/briefings-and-position-statements/allergy
World Allergy Organization. White book on allergy. Retrieved 18 December 2023
https://www.worldallergy.org/UserFiles/file/WhiteBook2-2013-v8.pdf
EC Union Register of medicinal products for human use. Retrieved 18 December 2023
https://ec.europa.eu/health/documents/community-register/html/h1495.htm
Roberts G, Pfaar O, Akdis A, Ansotegui IJ, Durham SR, Gerth van Wijk R, Halken S, Larenas-Linnemann D, Pawankar R, Pitsios C, Sheikh A, Worm M, Arasi S, Calderon MA, Cingi C, Dhami S, Fauquert JL, Hamelmann E, Hellings P, Jacobsen L, Know EF, Lin SY, Maggina P, Mösges R, Oude Elberink JNG, Pajno GB, Pastorello EA, Penagos M, Rotiroti G, Schmidt-Weber CB, Timmermans F, Tsilochristou O, Varga E-M, Wilkinson JN, Williams A, Zhang L, Agache I, Angier E, Fernandez-Rivas M, Jutel M, Lau S, van Ree R, Ryan D, Sturm GJ, Muraro A. European Journal of Allergy and Clinical Immunology (EAACI) Guidelines on Allergen Immunotherapy. Allergic rhinoconjunctivitis. 23 September 2017. doi.org/10.1111/all.13317
https://onlinelibrary.wiley.com/doi/10.1111/all.13317
Frew AJ. How does sublingual immunotherapy work? Journal of Allergy and Clinical Immunology. Vol 120, issue 3: p533-536, Sept 2007
https://www.jacionline.org/article/S0091-6749(07)01461-3/fulltext
Lund K, Kito H, Blem Skydtsgaard M, Nakazawa H, Ohashi-Doi K, Lawton S. The Importance of Tablet Formulation on Allergen Release Kinetics and Efficiency: Comparison of Freeze-dried and Compressed Grass Pollen Sublingual Allergy Immunotherapy Tablet Formulations. Clinical Therapeutics: vol 41, issue 4, 2019; p742-753. ISSN 0149-2918. doi.org/10.1016/j.clinthera.2019.02.008
https://www.sciencedirect.com/science/article/pii/S0149291819300682
Larenas-Linnemann DE, Epstein T, Ponda P, Bernstein D, Williams P, Creticos P. Gaps in allergen immunotherapy administration and subcutaneous allergen immunotherapy dose adjustment schedules: Need for prospective data. Ann Allergy Asthma Immunol. 2020;125(5):505-506.e2. doi:10.1016/j.anai.2020.07.015
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368643/
Calderón, M. A. et al. Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: Looking at the published evidence. J Allergy Clin Immunol 2012;129:929-3
https://www.jacionline.org/article/S0091-6749(11)01824-0/fulltext
Migueres M, Dávila I, Frati F, Azpeitia A, Jeanpetit Y, Lhéritier-Barrand M, Incorvaia C, Ciprandi G. Types of sensitization to aeroallergens: definitions, prevalences and impact on the diagnosis and treatment of allergic respiratory disease. Clin Transl Allergy. 2014 May 1;4:16. doi: 10.1186/2045-7022-4-16. eCollection 2014
https://www.ncbi.nlm.nih.gov/pubmed/24817997
Carlson G, Coop C. Pollen food allergy syndrome (PFAS): A review of current available literature. Annals of Allergy, Asthma & Immunology. Review vol123, issue 4, p359-365, Oct 2019. Published:July 31, 2019. doi.org/10.1016/j.anai.2019.07.022
https://www.annallergy.org/article/S1081-1206(19)30540-X/fulltext#secsectitle0045
Nolte H, Maloney J. The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases. Allergol Int. 2018 Jul;67(3):301-308. doi: 10.1016/j.alit.2018.03.008. Epub 2018 May 16
https://www.ncbi.nlm.nih.gov/pubmed/29759659
InformedHealth.org [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-. Hay fever: Allergen-specific immunotherapy (desensitization) in the treatment of allergies. [Updated 2020 Apr]
https://www.ncbi.nlm.nih.gov/books/NBK279487/
Di Bona D, Magistà S, Masciopinto L, Lovecchio A, Loiodice R, Bilancia M, Albanesi M, Caiaffa MF, Nettis E, Macchia L, Bariletto G, Carbonara A, Cataldo V, Damiani E, Di Leo E, Fiorino I, Kourtis G, Laudadio V, Loconte F, Lotti A, Mastromarco E, Nenna S, Nico A, Pietrafesa M, Rucco AS, Strada S.Safety and treatment compliance of subcutaneous immunotherapy: A 30-year retrospective study. Respiratory Medicine, Vol 161, 2020. 105843, ISSN 0954-6111. doi.org/10.1016/j.rmed.2019.105843
https://www.sciencedirect.com/science/article/pii/S0954611119303579
Cardona V, Ansotegui IJ, Ebisawa M, El-Gamal Y, Fernandez Rivas M, Fineman S, Geller M, Gonzalez-Estrada A, Greenberger PA, Sanchez Borges M, Senna G, Sheikh A, Kase Tanno L, Thong BY, Turner PJ, Worm M. World Allergy Organization Anaphylaxis Guidance 2020
https://www.worldallergyorganizationjournal.org/action/showPdf?pii=S1939-4551%2820%2930375-6
Pfaar, O. et al.: S2k-Leitlinie zur Allergen-Immuntherapie bei IgE-vermittelten allergischen Erkrankungen, Abgerufen am 30.03.2024 von:
https://register.awmf.org/de/leitlinien/detail/061-004
Ring, J. et al.: S2k-Leitlinie zur Akuttherapie und Management der Anaphylaxie. In: Allergo J Int 2014; 23: 96–112. AWMF-Register-Nr. 065-025, Abgerufen am 21.08.2023 von: https://register.awmf.org/de/leitlinien/detail/061-025
Grabenhenrich LB, Dölle S, Moneret-Vautrin A, Köhli A, Lange L, Spindler T, Ruëff F, Nemat K, Maris I, Roumpedaki E, Scherer K, Ott H, Reese T, Mustakov T, Lang R, Fernandez-Rivas M, Kowalski ML, Bilò MB, Hourihane JO, Papadopoulos NG, et al. Anaphylaxis in children and adolescents: The European Anaphylaxis Registry. J Allergy Clin Immunol. 2016; 137: 1128-1137.e1
Arzneiverordnungs-Report 2023; Wolf-Dieter Ludwig, Bernd Mühlbauer, Roland Seifert; Springer-Verlag GmbH; Kapitel 36, S. 741-754